A new study co-authored by University of Colorado Cancer Center researcher Srinivas Ramachandran, Ph.D., shows how DNA segments known as enhancers function in cells. The paper published last month in Molecular Cell highlighted the work from Ramachandran, along with Satyanarayan…
Read More
ACG updates guidelines for colorectal cancer screening
In the March issue of the American Journal of Gastroenterology, the American College of Gastroenterology has published updated recommendations for colorectal cancer (CRC) screening. Aasma Shaukat, M.D., M.P.H., from the University of Minnesota in Minneapolis, and colleagues updated the 2009…
Read More
Study reveals crucial details on skin-related side effects of cancer immune therapies
Immune checkpoint inhibitors, which boost the immune system’s response against tumor cells, have transformed treatment for many advanced cancers, but short-term clinical trials and small observational studies have linked the medications with various side effects, most commonly involving the skin….
Read More
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein to promote metastasis and tumor growth. Blocking CREB1 in preclinical…
Read More
Stress incontinence surgery does not increased risk of pelvic cancers
Women undergoing surgery to treat stress urinary incontinence (SUI) are not at increased risk of developing pelvic cancers, according to a large-scale, population-based study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is…
Read More
Mutations in overlooked DNA could have profound impact on survival for bowel cancer patients
Mutations in the DNA of the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a study published today in Nature Metabolism. Scientists funded by Cancer Research UK have found that patients with colorectal…
Read More
Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieved excellent outcomes, reduced side effects, and allowed for reduced radiation…
Read More
Breath Analysis: How Could it Improve Healthcare and Diagnosis?
insights from industrySanti Dominguez & Michael GrazCEO & Acting CEOImspex Diagnostics & Imspex Medical In this interview, News-Medical talks to Santi Dominguez and Michael Graz, CEOs atImspex Diagnostics and Imspex Medical respectively, about the role breath analysis has to play…
Read More
Fewer Cancer Deaths Attributed To Arsenic Reductions In Drinking Water
Arsenic is a natural element found not only in living things like animals and plants but also in water, soil, and air. The said element can be released into the environment from industrial and agricultural sources. The element is known to cause cancer…
Read More
Comorbidities lead to an increased risk of death from Covid-19, research shows
Comorbidities such as heart disease, respiratory disease, renal disease and cancer lead to an increased risk of death from Covid-19 according to new research from the University of East Anglia (UEA) and the Norfolk and Norwich University Hospital (NNUH). Image…
Read More